TACROLIMUS
MACROLIDE IMMUNOSUPPRESSANTS - TOPICAL · ATOPIC DERMATITIS ·+1
Padagis US
Drug class
Macrolide Immunosuppressants - Topical
Topical macrolide immunosuppressants—more widely categorized in clinical practice as topical calcineurin inhibitors—are a class of nonsteroidal immunomodulating agents that include tacrolimus and pimecrolimus. Read more about Macrolide Immunosuppressants - Topical
19 drugs in this class 9 manufacturers
Drugs in Macrolide Immunosuppressants - Topical
Filter & compare in the drug finder →
Opens the drug finder with Macrolide Immunosuppressants - Topical preselected. Add indication or manufacturer filters there.
Topical macrolide immunosuppressants—more widely categorized in clinical practice as topical calcineurin inhibitors—are a class of nonsteroidal immunomodulating agents that include tacrolimus and pimecrolimus.
Derived structurally from macrolide antibiotics, these agents bind to the intracellular immunophilin FKBP-12 to inhibit calcineurin phosphatase activity, thereby preventing T-lymphocyte activation and suppressing the transcription of proinflammatory cytokines.
They serve primarily as second-line, steroid-sparing topical treatments for inflammatory skin conditions, predominantly atopic dermatitis (eczema), offering an alternative that avoids corticosteroid-induced cutaneous atrophy.
-
fda.gov
Topical macrolide immunosuppressants—more widely categorized in clinical practice as topical calcineurin inhibitors—are a class of nonsteroidal immunomodulating agents that include tacrolimus and pimecrolimus They serve primarily as second-line, steroid-sparing topical treatments for inflammatory skin conditions, predominantly atopic dermatitis (eczema), offering an alternative that avoids corticosteroid-induced cutaneous atrophy
-
nextstepsinderm.com
Topical macrolide immunosuppressants—more widely categorized in clinical practice as topical calcineurin inhibitors—are a class of nonsteroidal immunomodulating agents that include tacrolimus and pimecrolimus Derived structurally from macrolide antibiotics, these agents bind to the intracellular immunophilin FKBP-12 to inhibit calcineurin phosphatase activity, thereby preventing T-lymphocyte activation and suppressing the transcription of proinflammatory cytokines
-
fda.gov
Derived structurally from macrolide antibiotics, these agents bind to the intracellular immunophilin FKBP-12 to inhibit calcineurin phosphatase activity, thereby preventing T-lymphocyte activation and suppressing the transcription of proinflammatory cytokines
-
manchester.ac.uk
They serve primarily as second-line, steroid-sparing topical treatments for inflammatory skin conditions, predominantly atopic dermatitis (eczema), offering an alternative that avoids corticosteroid-induced cutaneous atrophy
-
fda.gov
They serve primarily as second-line, steroid-sparing topical treatments for inflammatory skin conditions, predominantly atopic dermatitis (eczema), offering an alternative that avoids corticosteroid-induced cutaneous atrophy
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.